Schedule 13G ownership disclosure

Zenas Biopharma Inc

Common Stock, par value $0.0001 · CUSIP: 98937L105

Event date: 2025-03-25

Filing-level shares
2,214,967
Percent of class
5.3%
  • Novo Holdings A/S

    Shares: 2,214,967 · Class: 5.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-048850
Form type
SCHEDULE 13G
Filer
Novo Holdings A/S
CIK
CIK 1388325
Filed
Apr 01, 2025
Reporting period
Mar 25, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub